Treatments for attention-deficit/hyperactivity disorder
30 results
1 - 30
No association between stimulant treatment for attention-deficit/hyperactivity disorder and substance use- Neurofeedback is minimally, if at all, effective for attention-deficit/hyperactivity disorder
- Still no evidence of increased cardiovascular risk with attention-deficit/hyperactivity disorder medications
- 2019 guidelines for ADHD: structure plus medication
- ADHD: A lot of research, not a lot of guidance
- Higher risk of psychosis with amphetamines than methylphenidate in treatment of ADHD
- St. John's wort not effective for treatment of ADHD
- ADHD medications not associated with increased risk of CVD
- Antenatal corticosteroid exposure associated with mental and behavioral disorders
- Responders to atomoxetine do fine with lowered doses
- Atomoxetine better than placebo but not uniformly effective in young children
- Medical cannabis use not supported by a wealth of research
- Screening tool for adult ADHD of uncertain effectiveness
- Early adenotonsillectomy and watchful waiting both options for children with sleep apnea
- Comprehensive intervention in childhood reduces adult psychopathology